1000PDCopanlisib treatment in patients with relapsed or refractory indolent B-cell lymphoma: Subgroup analyses from the CHRONOS-1 study
Provencio Pulla, M., Santoro, A., Mollica, L., Leppä, S., Follows, G., Lenz, G., Kim, W.S., Nagler, A., Panayiotidis, P., Demeter, J., Özcan, M., Kosinova, M., Bouabdallah, K., Morschhauser, F., IshidVolume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx373.006
Date:
September, 2017
File:
PDF, 47 KB
english, 2017